Lin Ying, Gao Qing-Ping, Ye Bai-Xin
Department of Hematology, People's Hospital of Wuhan University, Wuhan 430060, Hubei Province, China.
Department of Hematology, People's Hospital of Wuhan University, Wuhan 430060, Hubei Province, China. E-mail:
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Jun;26(3):937-941. doi: 10.7534/j.issn.1009-2137.2018.03.052.
Pyroptosis is a novel type of programmed cell death, which is closely related with the pathogenesis of myelodysplastic syndromes (MDS). The recent studies showed that all of S100A9/TLR4, S100A9/CD33 and Nox/ROS signaling pathways can activate oxygen-sensitivity NLRP3 inflammasome and then induce the pyroptosis of hematopoeitic stem cells (HSC) / hematopeitic pregenitor cells (HPC), resulting in ineffective hematopoiesis in patients with MDS. Further studies on the role and molecular mechanism of pyroptosis in the pathogenesis of MDS will provide the potential opportunity for the diagnosis and treatment of MDS. Here, the recent advances in the role and mechnism of pyroptosis in the pathogenesis of MDS are reviewed.
细胞焦亡是一种新型的程序性细胞死亡,与骨髓增生异常综合征(MDS)的发病机制密切相关。最近的研究表明,S100A9/TLR4、S100A9/CD33和Nox/ROS信号通路均可激活氧敏感性NLRP3炎性小体,进而诱导造血干细胞(HSC)/造血祖细胞(HPC)发生细胞焦亡,导致MDS患者造血无效。进一步研究细胞焦亡在MDS发病机制中的作用及分子机制,将为MDS的诊断和治疗提供潜在机会。在此,对细胞焦亡在MDS发病机制中的作用及机制的最新研究进展进行综述。